STEVEN KING: Open Payments
NPI 1629069083 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 19 payments from 10 companies in 2025. Trend: 2023 $332 · 2024 $384 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $69 |
| Exact Sciences Corporation | 3 | $53 |
| Novo Nordisk Inc | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Optinose US, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $36 |
| PFIZER INC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: AJOVY, Cologuard Collection Kit, Xhance, VRAYLAR, NURTEC ODT, Ozempic, BREZTRI, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
